期刊文献+

植酸酮治疗HPV感染合并CINⅠ期的临床疗效观察 被引量:6

下载PDF
导出
摘要 目的:探讨植酸酮妇科清洗装置(商品名:美福康)Ⅱ型对于人乳头瘤病毒(HPV)感染合并宫颈上皮内瘤变(CIN)Ⅰ期的作用及疗效分析。方法:将60例HPV感染合并CINⅠ期患者随机分为治疗组(植酸酮Ⅱ型组30例)与对照组(重组人干扰素α2b,即辛复宁组30例)。用药3个疗程后,观察疗效。结果:治疗组总有效率86.67%,对照组总有效率40.00%(P<0.05);治疗组中未转阴患者HPV-DNA病毒载量明显下降,与对照组比较差异有统计学意义(P<0.05)。结论:植酸酮妇科清洗装置Ⅱ型作为一种生物制剂用于治疗HPV高危亚型感染合并CINⅠ期有显著疗效,适于临床推广。
出处 《国际妇产科学杂志》 CAS 2012年第5期535-536,共2页 Journal of International Obstetrics and Gynecology
  • 相关文献

参考文献8

  • 1Steben M,Duarte-Franco E. Human papillomavims infection: epidemiology and pathophysiology [ J ]. Gynecol Oncol, 2007,107 ( 2 Suppl 1 ) : 2-5.
  • 2张晓静,袁瑞,代红莹.重庆永川地区妇科门诊人乳头瘤病毒亚型分布的研究[J].重庆医科大学学报,2010,35(9):1407-1410. 被引量:31
  • 3Paavonen J. Human papillnmavirus infection and the development of cervical cancer and related genital neoplasias [J 1. Int J Infect Dis, 2007,11 (Suppl 2) :3-9.
  • 4Herzog TJ, Wright JD. The impact of cervical cancer on quality of life the components and means for management [J] . Gynecol Oncol, 2007, 107(3) : 572-577.
  • 5石清芳,李淑鸾,周庆云,韩彩娥.液基涂片细胞学检查联合高危型HPV检测在宫颈病变诊断中的价值[J].中国妇幼保健,2008,23(3):381-383. 被引量:6
  • 6Ma BW, GuoYQ, Ma LL. Detection of abnormal cervical epithelial by liquid based cytology technique [J ]. Chin J Pathol, 2004. 33 (3): 287-290.
  • 7Biscotti CV ,Dawson AE ,Dziur AB ,et al. Assited primary screening using the automated thin prep imaging system [J ]. Am J Clin Pathol, 2005,123(2) :281-287.
  • 8Albrecht V,Chevallier A, Magnone V, et al. Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays [J ]. J Virol Methods, 2006,137 (2): 256-244.

二级参考文献17

  • 1蔡虹.深圳市城区育龄妇女HPV感染状况调查[J].中国妇幼保健,2004,19(9):90-92. 被引量:46
  • 2吴玉萍,陈裕隆,李隆玉,梁增文,张雁玲.宫颈癌患者人乳头瘤病毒(HPV)主要型别及其感染研究[J].病毒学报,2005,21(4):269-273. 被引量:56
  • 3李晓红,董卫红,黄在菊,张惠芳,王泽华.子宫颈癌前病变组织DNA倍体分析与人乳头状瘤病毒亚型检测[J].中华妇产科杂志,2006,41(3):205-206. 被引量:19
  • 4杨英捷,赵健,李雪倩,廖秦平.2285例女性下生殖道人乳头状瘤病毒感染筛查结果分析[J].中国实用妇科与产科杂志,2006,22(6):444-445. 被引量:95
  • 5Steben M,Duarte-Franco E.Human papillomavirus infectiou:Epidemiology and pathophysi-ology[J].Gynecologic Ontology,2007,107(S1):2-5.
  • 6Paavouen J.Human papillomavirus infectiou and the development of cervical cancer and related genital neoplasias[J].International Journal of Infectious Diseases,2007,11(S2):3-9.
  • 7Clifford G M,Gallus S,Herrero R,et al.Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys:a pooled analysis[J].Lancet,2005,366(9490):991-998.
  • 8de Sanjosé S,Diaz M,Caatellsagué X,et al.Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology:a meta-analysis[J].Lancet Infect Dis,2007,7(7):453-459.
  • 9Gargiulo F,Francesco M A De,Schreiber C,et al.Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women[J].Virus Research,2007,125(2):176-182.
  • 10Albrecht V,Chevallier A,Magnone V,et al.Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA Microarrays[J].Journal of Virological Methods,2006,137(2):236-244.

共引文献35

同被引文献45

  • 1谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 2Hamada K,Shirakawa T,Gotoh A,et al.Adenovirus-mediatedtransfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer[J].Gynecol Oncol,2006,103(3):820-830.
  • 3Garland SM,Bhatla N,Ngan HY.Cervical cancer burden and prevention strategies:Asia Oceania perspective[J].Cancer Epidemiol Biomarkers Prev,2012,21(9):1414-1422.
  • 4Albrecht V,Chevallier A,Magnone V,et al.Easy and fast detectionand genotyping of high-risk human papillomavirus by dedicated DNA microarrays[J].J Virol Methods,2006,137(2):236-244.
  • 5Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillo- mavirus is a necessary cause of invasive cervical cancer worldwide [J]. J Pathol, 1999,159(1) :12-19.
  • 6zur Hausen H. Papillomaviruses in the causation of human cancers- a brief historical account[J]. Virology, 2009,384(2) :260-265.
  • 7Mighty KK, Laimins LA. The role of human papillomaviruses in oncogenesis [J]. Recent Results Cancer Res, 2014, (,193) : 135- 148.
  • 8Moody CA, Laimins LA. Human papillomavirus oncoproteins : pathways to transformation [ J ]. Nat Rev Cancer, 2010,10 ( 8 ) : 550-560.
  • 9Ganguly N, Parihar SP. Human papillmavirus E6 and E7 oneopro- teins as risk factors for tumorigenesis[ J]. J Biosei, 2009,34( 1 ) : 113-123.
  • 10Ghittoni R, Accardi R, Chiocca S, et al. Role of human papilloma- viruses in carcinogenesis[J]. Ecancer Med Sci, 2015,9(4) :526.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部